Primary Sjögren's Syndrome (pSS)
7
2
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (7)
Efficacy of Tocilizumab in Primary Sjögren's Syndrome.
A Study of Yiqi Yangyin Formula in the Treatment of Primary Sjogren's Syndrome
Current Therapy in Primary Sjogren's Syndrome
Therapeutic Effect of Upadacitinib in Primary Sjögren's Syndrome
New Clinical End-points in Patients With Primary Sjögren's Syndrome
Clinical Study to Investigate the Efficacy of Orally Administered SA001 in Patients With Primary Sjögren's Syndrome
Diagnostic Suspicion of Primitive Syndrome Sjögren's : Brest Cohort